Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 6
2000 3
2001 9
2002 4
2003 7
2004 2
2005 10
2006 2
2007 2
2008 4
2009 6
2010 6
2011 6
2012 4
2013 5
2014 4
2015 1
2016 3
2017 2
2018 4
2020 3
2021 7
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

95 results
Results by year
Filters applied: . Clear all
Page 1
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M, Gentilini O, Mastropasqua MG, Mazzarol G, Massarut S, Garbay JR, Zgajnar J, Galatius H, Recalcati A, Littlejohn D, Bamert M, Colleoni M, Price KN, Regan MM, Goldhirsch A, Coates AS, Gelber RD, Veronesi U; International Breast Cancer Study Group Trial 23-01 investigators. Galimberti V, et al. Among authors: mazzarol g. Lancet Oncol. 2013 Apr;14(4):297-305. doi: 10.1016/S1470-2045(13)70035-4. Epub 2013 Mar 11. Lancet Oncol. 2013. PMID: 23491275 Free PMC article. Clinical Trial.
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
Galimberti V, Cole BF, Viale G, Veronesi P, Vicini E, Intra M, Mazzarol G, Massarut S, Zgajnar J, Taffurelli M, Littlejohn D, Knauer M, Tondini C, Di Leo A, Colleoni M, Regan MM, Coates AS, Gelber RD, Goldhirsch A; International Breast Cancer Study Group Trial 23-01. Galimberti V, et al. Among authors: mazzarol g. Lancet Oncol. 2018 Oct;19(10):1385-1393. doi: 10.1016/S1470-2045(18)30380-2. Epub 2018 Sep 5. Lancet Oncol. 2018. PMID: 30196031 Clinical Trial.
Cutaneous melanoma in the elderly.
Testori A, Soteldo J, Sances D, Mazzarol G, Trifirò G, Zonta M, Rastrelli M, Schenone F, Verrecchia F. Testori A, et al. Among authors: mazzarol g. Melanoma Res. 2009 Jun;19(3):125-34. doi: 10.1097/CMR.0b013e328329fe95. Melanoma Res. 2009. PMID: 19381113 Review.
Aggressive digital papillary adenocarcinoma.
Rastrelli M, Soteldo J, Vitali GC, Mazzarol G, Trifiro G, Tosti G, Testori A. Rastrelli M, et al. Among authors: mazzarol g. Indian J Cancer. 2011 Jan-Mar;48(1):126-7. doi: 10.4103/0019-509X.76641. Indian J Cancer. 2011. PMID: 21330762 Free article. No abstract available.
Different Response to Immunotherapy According to Melanoma Histologic Subtype.
Pala L, Conforti F, Pagan E, Bagnardi V, De Pas TM, Mazzarol G, Barberis M, Pennacchioli E, Orsolini G, Prestianni P, Zagami P, Nicolo' E, Patanè D, Saponara M, Queirolo P. Pala L, et al. Among authors: mazzarol g. J Immunother. 2021 Dec 15. doi: 10.1097/CJI.0000000000000403. Online ahead of print. J Immunother. 2021. PMID: 34908006
Dual regulation of Myc by Abl.
Sanchez-Arévalo Lobo VJ, Doni M, Verrecchia A, Sanulli S, Fagà G, Piontini A, Bianchi M, Conacci-Sorrell M, Mazzarol G, Peg V, Losa JH, Ronchi P, Ponzoni M, Eisenman RN, Doglioni C, Amati B. Sanchez-Arévalo Lobo VJ, et al. Among authors: mazzarol g. Oncogene. 2013 Nov 7;32(45):5261-71. doi: 10.1038/onc.2012.621. Epub 2013 Jan 14. Oncogene. 2013. PMID: 23318434 Free PMC article.
95 results